NEW YORK--(BUSINESS WIRE)--Delcath Systems, Inc. (Nasdaq:DCTH) announced today that the Company’s high dose percutaneous perfusion technology for delivery of therapeutic and chemotherapeutic agents to isolated regions and organs of the body, the Delcath System, will be highlighted in the October 19, 2007 edition of “Clinica World Medical Technology News,” a leading international medical technology news publication. The article profiles Delcath in a discussion of three companies that presented at the 15th Annual BioPartnering Europe conference in London, England last week. Delcath also presented at the Biotechnica Partnering Conference in Hanover, Germany last week, as part of its strategy to meet with major European drug, biotechnology and medical device companies to expand awareness of the Company’s unique Percutaneous Hepatic Perfusion technology.
